Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-16
Closed -$148 3200
2024
Q1
$148 Buy
+16
New +$188 ﹤0.01% 3117
2023
Q4
Sell
-13
Closed -$134 3205
2023
Q3
$134 Buy
+13
New +$151 ﹤0.01% 3131
2022
Q4
Sell
-31
Closed -$1K 3360
2022
Q3
$1K Buy
+31
New +$571 ﹤0.01% 2987
2022
Q2
Sell
-199
Closed -$5K 3249
2022
Q1
$5K Buy
+199
New +$5.14K ﹤0.01% 2483

Other funds holding LUNG

SignatureFD's LUNG Position: Q2 2024 in Review

SignatureFD sold out of Pulmonx (LUNG) in Q2 2024, closing a stake of 16 shares — an estimated $148 sold.

SignatureFD first reported a position in LUNG in Q1 2022 and held it in 4 quarters. The position peaked at $5K in Q1 2022. 111 funds tracked by Wall St. Rank hold LUNG as of Q2 2024.

  • SignatureFD reported no remaining Pulmonx position as of Q2 2024 after selling out during the quarter.
  • SignatureFD sold 16 Pulmonx shares in Q2 2024, an estimated $148.
  • SignatureFD first reported a position in Pulmonx in Q1 2022 and held it in 4 quarters.
  • SignatureFD's Pulmonx position peaked at $5K in Q1 2022.
  • 111 funds tracked by Wall St. Rank held Pulmonx as of Q2 2024.

Based on SignatureFD's 13F filing for Q2 2024, filed 29 Jul 2024.